Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Type 2 diabetic subjects
Current treatment with Biphasic Human Insulin 30/70 twice daily alone or in combination with any oral hypoglycaemic agent for at least 3 months prior to entering the trial
HbA1c at least 12%
Willing and able to perform self blood glucose monitoring (SMBG)
You may not be if
History of drug or alcohol dependence
Receipt of any investigational drug within the last month prior to this trial
Anticipated change in dose of prescription medication, which may influence glucose regulation (Mono Amino Oxidase-inhibitors, non selective beta-adrenergic agents, anabolic steroids and systemic glucocorticoids)
Severe uncontrolled hypertension
Recurrent severe hypoglycemia as judged by investigator
Any disease or condition, which the Investigator feels, would interfere with the trial
